APO Research
Talk to an analyst

APO RESEARCH · REPORT

Glutamate Receptor Ionotropic NMDA 2B

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Glutamate Receptor Ionotropic NMDA 2B Market Outlook and Growth Opportunities 2026

26 December 2025197 pages

Choose your research edition.

Industry ResearchGlutamate Receptor Ionotropic NMDA 2B Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Glutamate Receptor Ionotropic NMDA 2B Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Glutamate Receptor Ionotropic NMDA 2B Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glutamate Receptor Ionotropic NMDA 2B Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Glutamate Receptor Ionotropic NMDA 2B Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Glutamate Receptor Ionotropic NMDA 2B market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Glutamate Receptor Ionotropic NMDA 2B is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Glutamate Receptor Ionotropic NMDA 2B is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Glutamate Receptor Ionotropic NMDA 2B is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Glutamate Receptor Ionotropic NMDA 2B market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Glutamate Receptor Ionotropic NMDA 2B market include Johnson & Johnson, Novartis AG, UCB S.A., NeurOp, Inc, Luc Therapeutics, Inc., Cerecor Inc., Bristol-Myers Squibb Company and BioCrea GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Glutamate Receptor Ionotropic NMDA 2B market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Glutamate Receptor Ionotropic NMDA 2B and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Glutamate Receptor Ionotropic NMDA 2B sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Glutamate Receptor Ionotropic NMDA 2B market size, projected growth trends, production technologies, key applications, and end-use industries.

Glutamate Receptor Ionotropic NMDA 2B Segment by Company

Johnson & Johnson

Novartis AG

UCB S.A.

NeurOp, Inc

Luc Therapeutics, Inc.

Cerecor Inc.

Bristol-Myers Squibb Company

BioCrea GmbH

Glutamate Receptor Ionotropic NMDA 2B Segment by Type

JNJ-0808

Radiprodil

NP-11948

NP-10679

Neu-2000

Others

Glutamate Receptor Ionotropic NMDA 2B Segment by Application

Burns

Acute Ischemic Stroke

Brain Ischemia

Autism

Others

Glutamate Receptor Ionotropic NMDA 2B Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Glutamate Receptor Ionotropic NMDA 2B status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Glutamate Receptor Ionotropic NMDA 2B market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Glutamate Receptor Ionotropic NMDA 2B significant trends, drivers, influence factors in global and regions.

6. To analyze Glutamate Receptor Ionotropic NMDA 2B competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glutamate Receptor Ionotropic NMDA 2B market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glutamate Receptor Ionotropic NMDA 2B and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glutamate Receptor Ionotropic NMDA 2B.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Glutamate Receptor Ionotropic NMDA 2B market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Glutamate Receptor Ionotropic NMDA 2B industry.

Chapter 3: Detailed analysis of Glutamate Receptor Ionotropic NMDA 2B manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Glutamate Receptor Ionotropic NMDA 2B in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Glutamate Receptor Ionotropic NMDA 2B in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Glutamate Receptor Ionotropic NMDA 2B Industry Trends Table 2. Glutamate Receptor Ionotropic NMDA 2B Industry Drivers Table 3. Glutamate Receptor Ionotropic NMDA 2B Industry Opportunities and Challenges Table 4. Glutamate Receptor Ionotropic NMDA 2B Industry Restraints Table 5. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Company (2021-2026) Table 7. Global Glutamate Receptor Ionotropic NMDA 2B Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Glutamate Receptor Ionotropic NMDA 2B Sales Volume Share by Company (2021-2026) Table 9. Global Glutamate Receptor Ionotropic NMDA 2B Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Glutamate Receptor Ionotropic NMDA 2B Company Ranking, (2024-2026) & (USD Million) Table 11. Global Glutamate Receptor Ionotropic NMDA 2B Key Company Manufacturing Base & Headquarters Table 12. Global Glutamate Receptor Ionotropic NMDA 2B Company, Product Type & Application Table 13. Global Glutamate Receptor Ionotropic NMDA 2B Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Glutamate Receptor Ionotropic NMDA 2B by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of JNJ-0808 Table 18. Significant Companies of Radiprodil Table 19. Significant Companies of NP-11948 Table 20. Significant Companies of NP-10679 Table 21. Significant Companies of Neu-2000 Table 22. Significant Companies of Others Table 23. Global Glutamate Receptor Ionotropic NMDA 2B Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 24. Global Glutamate Receptor Ionotropic NMDA 2B Sales Volume by Type (2021-2026) & (W Units) Table 25. Global Glutamate Receptor Ionotropic NMDA 2B Sales Volume by Type (2027-2032) & (W Units) Table 26. Global Glutamate Receptor Ionotropic NMDA 2B Sales Volume Share by Type (2021-2026) Table 27. Global Glutamate Receptor Ionotropic NMDA 2B Sales Volume Share by Type (2027-2032) Table 28. Global Glutamate Receptor Ionotropic NMDA 2B Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Glutamate Receptor Ionotropic NMDA 2B Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Glutamate Receptor Ionotropic NMDA 2B Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type (2021-2026) Table 32. Global Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Burns Table 34. Significant Companies of Acute Ischemic Stroke Table 35. Significant Companies of Brain Ischemia Table 36. Significant Companies of Autism Table 37. Significant Companies of Others Table 38. Global Glutamate Receptor Ionotropic NMDA 2B Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 39. Global Glutamate Receptor Ionotropic NMDA 2B Sales Volume by Application (2021-2026) & (W Units) Table 40. Global Glutamate Receptor Ionotropic NMDA 2B Sales Volume by Application (2027-2032) & (W Units) Table 41. Global Glutamate Receptor Ionotropic NMDA 2B Sales Volume Share by Application (2021-2026) Table 42. Global Glutamate Receptor Ionotropic NMDA 2B Sales Volume Share by Application (2027-2032) Table 43. Global Glutamate Receptor Ionotropic NMDA 2B Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 44. Global Glutamate Receptor Ionotropic NMDA 2B Sales Value by Application (2021-2026) & (US$ Million) Table 45. Global Glutamate Receptor Ionotropic NMDA 2B Sales Value by Application (2027-2032) & (US$ Million) Table 46. Global Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application (2021-2026) Table 47. Global Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application (2027-2032) Table 48. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 49. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2021-2026) & (W Units) Table 50. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Region (2021-2026) Table 51. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2027-2032) & (W Units) Table 52. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Region (2027-2032) Table 53. Global Glutamate Receptor Ionotropic NMDA 2B Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 54. Global Glutamate Receptor Ionotropic NMDA 2B Sales Value by Region (2021-2026) & (US$ Million) Table 55. Global Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Region (2021-2026) Table 56. Global Glutamate Receptor Ionotropic NMDA 2B Sales Value by Region (2027-2032) & (US$ Million) Table 57. Global Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Region (2027-2032) Table 58. Global Glutamate Receptor Ionotropic NMDA 2B Market Average Price (US$/Unit) by Region (2021-2026) Table 59. Global Glutamate Receptor Ionotropic NMDA 2B Market Average Price (US$/Unit) by Region (2027-2032) Table 60. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 61. Global Glutamate Receptor Ionotropic NMDA 2B Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2021-2026) & (W Units) Table 63. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country (2021-2026) Table 64. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2027-2032) & (W Units) Table 65. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country (2027-2032) Table 66. Global Glutamate Receptor Ionotropic NMDA 2B Sales Value by Country (2021-2026) & (US$ Million) Table 67. Global Glutamate Receptor Ionotropic NMDA 2B Sales Value Market Share by Country (2021-2026) Table 68. Global Glutamate Receptor Ionotropic NMDA 2B Sales Value by Country (2027-2032) & (US$ Million) Table 69. Global Glutamate Receptor Ionotropic NMDA 2B Sales Value Market Share by Country (2027-2032) Table 70. Johnson & Johnson Company Information Table 71. Johnson & Johnson Business Overview Table 72. Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Product Portfolio Table 74. Johnson & Johnson Recent Development Table 75. Novartis AG Company Information Table 76. Novartis AG Business Overview Table 77. Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Novartis AG Glutamate Receptor Ionotropic NMDA 2B Product Portfolio Table 79. Novartis AG Recent Development Table 80. UCB S.A. Company Information Table 81. UCB S.A. Business Overview Table 82. UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Product Portfolio Table 84. UCB S.A. Recent Development Table 85. NeurOp, Inc Company Information Table 86. NeurOp, Inc Business Overview Table 87. NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Product Portfolio Table 89. NeurOp, Inc Recent Development Table 90. Luc Therapeutics, Inc. Company Information Table 91. Luc Therapeutics, Inc. Business Overview Table 92. Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Product Portfolio Table 94. Luc Therapeutics, Inc. Recent Development Table 95. Cerecor Inc. Company Information Table 96. Cerecor Inc. Business Overview Table 97. Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Product Portfolio Table 99. Cerecor Inc. Recent Development Table 100. Bristol-Myers Squibb Company Company Information Table 101. Bristol-Myers Squibb Company Business Overview Table 102. Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Product Portfolio Table 104. Bristol-Myers Squibb Company Recent Development Table 105. BioCrea GmbH Company Information Table 106. BioCrea GmbH Business Overview Table 107. BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Product Portfolio Table 109. BioCrea GmbH Recent Development Table 110. Key Raw Materials Table 111. Raw Materials Key Suppliers Table 112. Glutamate Receptor Ionotropic NMDA 2B Distributors List Table 113. Glutamate Receptor Ionotropic NMDA 2B Customers List Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Glutamate Receptor Ionotropic NMDA 2B Product Image Figure 2. Global Glutamate Receptor Ionotropic NMDA 2B Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glutamate Receptor Ionotropic NMDA 2B Sales Value (2021-2032) & (US$ Million) Figure 4. Global Glutamate Receptor Ionotropic NMDA 2B Sales (2021-2032) & (W Units) Figure 5. Global Glutamate Receptor Ionotropic NMDA 2B Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Glutamate Receptor Ionotropic NMDA 2B Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. JNJ-0808 Image Figure 10. Radiprodil Image Figure 11. NP-11948 Image Figure 12. NP-10679 Image Figure 13. Neu-2000 Image Figure 14. Others Image Figure 15. Global Glutamate Receptor Ionotropic NMDA 2B Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 16. Global Glutamate Receptor Ionotropic NMDA 2B Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Glutamate Receptor Ionotropic NMDA 2B Sales Volume Share by Type (2021-2032) Figure 18. Global Glutamate Receptor Ionotropic NMDA 2B Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Glutamate Receptor Ionotropic NMDA 2B Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type (2021-2032) Figure 21. Burns Image Figure 22. Acute Ischemic Stroke Image Figure 23. Brain Ischemia Image Figure 24. Autism Image Figure 25. Others Image Figure 26. Global Glutamate Receptor Ionotropic NMDA 2B Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 27. Global Glutamate Receptor Ionotropic NMDA 2B Sales Volume Share 2021 VS 2025 VS 2032 Figure 28. Global Glutamate Receptor Ionotropic NMDA 2B Sales Volume Share by Application (2021-2032) Figure 29. Global Glutamate Receptor Ionotropic NMDA 2B Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Glutamate Receptor Ionotropic NMDA 2B Sales Value Share 2021 VS 2025 VS 2032 Figure 31. Global Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application (2021-2032) Figure 32. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 33. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 34. Global Glutamate Receptor Ionotropic NMDA 2B Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 35. Global Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 36. North America Glutamate Receptor Ionotropic NMDA 2B Sales Value (2021-2032) & (US$ Million) Figure 37. North America Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Value (2021-2032) & (US$ Million) Figure 39. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Value (2021-2032) & (US$ Million) Figure 41. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Country (%), 2025 VS 2032 Figure 42. South America Glutamate Receptor Ionotropic NMDA 2B Sales Value (2021-2032) & (US$ Million) Figure 43. South America Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Country (%), 2025 VS 2032 Figure 44. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales Value (2021-2032) & (US$ Million) Figure 45. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Country (%), 2025 VS 2032 Figure 46. USA Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. USA Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. USA Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Canada Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Canada Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Canada Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Mexico Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Mexico Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Mexico Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Germany Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Germany Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Germany Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. France Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. France Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. France Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. U.K. Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. U.K. Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. U.K. Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Italy Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Italy Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Italy Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Spain Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Spain Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Spain Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Russia Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Russia Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Russia Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Netherlands Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Netherlands Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Netherlands Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Nordic Countries Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Nordic Countries Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Nordic Countries Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. China Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. China Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. China Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Japan Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Japan Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Japan Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. South Korea Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. South Korea Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. South Korea Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. India Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. India Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. India Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Australia Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Australia Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Australia Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Brazil Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Brazil Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Brazil Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Argentina Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Argentina Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Argentina Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Chile Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Chile Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Chile Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Colombia Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Colombia Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Colombia Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Peru Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Peru Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Peru Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Saudi Arabia Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Saudi Arabia Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Israel Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Israel Arabia Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Israel Arabia Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. UAE Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. UAE Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. UAE Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Turkey Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Turkey Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Turkey Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Iran Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Iran Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Iran Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Egypt Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 128. Egypt Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 129. Egypt Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 130. Glutamate Receptor Ionotropic NMDA 2B Value Chain Figure 131. Manufacturing Cost Structure Figure 132. Glutamate Receptor Ionotropic NMDA 2B Sales Mode & Process Figure 133. Direct Comparison with Distribution Share Figure 134. Distributors Profiles Figure 135. Years Considered Figure 136. Research Process Figure 137. Key Executives Interviewed

Scope & coverage.

Types
  • JNJ-0808
  • Radiprodil
  • NP-11948
  • NP-10679
  • Neu-2000
  • Others
Applications
  • Burns
  • Acute Ischemic Stroke
  • Brain Ischemia
  • Autism
  • Others
Companies covered
  • Johnson & Johnson
  • Novartis AG
  • UCB S.A.
  • NeurOp, Inc
  • Luc Therapeutics, Inc.
  • Cerecor Inc.
  • Bristol-Myers Squibb Company
  • BioCrea GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales Value (2021-2032)
  4. 1.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales Volume (2021-2032)
  5. 1.2.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Glutamate Receptor Ionotropic NMDA 2B Market Dynamics
  1. 2.1 Glutamate Receptor Ionotropic NMDA 2B Industry Trends
  2. 2.2 Glutamate Receptor Ionotropic NMDA 2B Industry Drivers
  3. 2.3 Glutamate Receptor Ionotropic NMDA 2B Industry Opportunities and Challenges
  4. 2.4 Glutamate Receptor Ionotropic NMDA 2B Industry Restraints
3 Glutamate Receptor Ionotropic NMDA 2B Market by Company
  1. 3.1 Global Glutamate Receptor Ionotropic NMDA 2B Company Revenue Ranking in 2025
  2. 3.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Company (2021-2026)
  3. 3.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales Volume by Company (2021-2026)
  4. 3.4 Global Glutamate Receptor Ionotropic NMDA 2B Average Price by Company (2021-2026)
  5. 3.5 Global Glutamate Receptor Ionotropic NMDA 2B Company Ranking (2024-2026)
  6. 3.6 Global Glutamate Receptor Ionotropic NMDA 2B Company Manufacturing Base and Headquarters
  7. 3.7 Global Glutamate Receptor Ionotropic NMDA 2B Company Product Type and Application
  8. 3.8 Global Glutamate Receptor Ionotropic NMDA 2B Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Glutamate Receptor Ionotropic NMDA 2B Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Glutamate Receptor Ionotropic NMDA 2B Market by Type
  1. 4.1 Glutamate Receptor Ionotropic NMDA 2B Type Introduction
  2. 4.1.1 JNJ-0808
  3. 4.1.2 Radiprodil
  4. 4.1.3 NP-11948
  5. 4.1.4 NP-10679
  6. 4.1.5 Neu-2000
  7. 4.1.6 Others
  8. 4.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales Volume by Type
  9. 4.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales Value by Type
  13. 4.3.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales Value by Type (2021-2032)
  15. 4.3.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type (2021-2032)
5 Glutamate Receptor Ionotropic NMDA 2B Market by Application
  1. 5.1 Glutamate Receptor Ionotropic NMDA 2B Application Introduction
  2. 5.1.1 Burns
  3. 5.1.2 Acute Ischemic Stroke
  4. 5.1.3 Brain Ischemia
  5. 5.1.4 Autism
  6. 5.1.5 Others
  7. 5.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales Volume by Application
  8. 5.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales Value by Application
  12. 5.3.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales Value by Application (2021-2032)
  14. 5.3.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application (2021-2032)
6 Glutamate Receptor Ionotropic NMDA 2B Regional Sales and Value Analysis
  1. 6.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2021-2032)
  3. 6.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region: 2021-2026
  4. 6.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2027-2032)
  5. 6.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Glutamate Receptor Ionotropic NMDA 2B Sales Value by Region (2021-2032)
  7. 6.4.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales Value by Region: 2021-2026
  8. 6.4.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales Value by Region (2027-2032)
  9. 6.5 Global Glutamate Receptor Ionotropic NMDA 2B Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Glutamate Receptor Ionotropic NMDA 2B Sales Value (2021-2032)
  12. 6.6.2 North America Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Glutamate Receptor Ionotropic NMDA 2B Sales Value (2021-2032)
  15. 6.7.2 Europe Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Glutamate Receptor Ionotropic NMDA 2B Sales Value (2021-2032)
  21. 6.9.2 South America Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Country, 2025 VS 2032
7 Glutamate Receptor Ionotropic NMDA 2B Country-level Sales and Value Analysis
  1. 7.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2021-2032)
  4. 7.3.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2021-2026)
  5. 7.3.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2027-2032)
  6. 7.4 Global Glutamate Receptor Ionotropic NMDA 2B Sales Value by Country (2021-2032)
  7. 7.4.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales Value by Country (2021-2026)
  8. 7.4.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Glutamate Receptor Ionotropic NMDA 2B Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Glutamate Receptor Ionotropic NMDA 2B Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Novartis AG
  8. 8.2.1 Novartis AG Company Information
  9. 8.2.2 Novartis AG Business Overview
  10. 8.2.3 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
  12. 8.2.5 Novartis AG Recent Developments
  13. 8.3 UCB S.A.
  14. 8.3.1 UCB S.A. Company Information
  15. 8.3.2 UCB S.A. Business Overview
  16. 8.3.3 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
  18. 8.3.5 UCB S.A. Recent Developments
  19. 8.4 NeurOp, Inc
  20. 8.4.1 NeurOp, Inc Company Information
  21. 8.4.2 NeurOp, Inc Business Overview
  22. 8.4.3 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
  24. 8.4.5 NeurOp, Inc Recent Developments
  25. 8.5 Luc Therapeutics, Inc.
  26. 8.5.1 Luc Therapeutics, Inc. Company Information
  27. 8.5.2 Luc Therapeutics, Inc. Business Overview
  28. 8.5.3 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
  30. 8.5.5 Luc Therapeutics, Inc. Recent Developments
  31. 8.6 Cerecor Inc.
  32. 8.6.1 Cerecor Inc. Company Information
  33. 8.6.2 Cerecor Inc. Business Overview
  34. 8.6.3 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
  36. 8.6.5 Cerecor Inc. Recent Developments
  37. 8.7 Bristol-Myers Squibb Company
  38. 8.7.1 Bristol-Myers Squibb Company Company Information
  39. 8.7.2 Bristol-Myers Squibb Company Business Overview
  40. 8.7.3 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
  42. 8.7.5 Bristol-Myers Squibb Company Recent Developments
  43. 8.8 BioCrea GmbH
  44. 8.8.1 BioCrea GmbH Company Information
  45. 8.8.2 BioCrea GmbH Business Overview
  46. 8.8.3 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
  48. 8.8.5 BioCrea GmbH Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Glutamate Receptor Ionotropic NMDA 2B Value Chain Analysis
  2. 9.1.1 Glutamate Receptor Ionotropic NMDA 2B Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Glutamate Receptor Ionotropic NMDA 2B Sales Mode & Process
  6. 9.2 Glutamate Receptor Ionotropic NMDA 2B Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Glutamate Receptor Ionotropic NMDA 2B Distributors
  9. 9.2.3 Glutamate Receptor Ionotropic NMDA 2B Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst